-
Premium No Longer Deserved? Why Brean's Difei Yang Is Downgrading Horizon Pharma
Tuesday, September 22, 2015 - 9:16am | 345Although Horizon Pharma PLC (NASDAQ: HZNP) shares have declined since September 21, they are up 128 percent since September 15. Brean's Difei Yang downgraded the rating on the company from Buy to Hold, while removing the price target. Recent negative developments for the sector as...
-
EA, Take-Two Ride Activision's Earnings To Gains
Wednesday, August 5, 2015 - 2:10pm | 338Shares of Activision Blizzard, Inc. (NASDAQ: ATVI) were up more than 12 percent on Wednesday after the company beat earnings and revenue estimates. The company posted earnings of $0.13 per share on revenue of $759 million, ahead of guidance that called for earnings of $0.07 per share...
-
June Video Game Sales Are Out; What Do They Show?
Friday, July 17, 2015 - 8:17am | 397In a report published Friday, Brean analyst Todd Mitchell analyzed June's NPD retail video game industry sales, which showed an 18 percent increase in video game industry sales during June to $69 million. Mitchell commented that the sales growth came from a 20 percent jump in software sales...
-
Brean And Wedbush Both Think EA's Guidance Is Conservative: Here's Why
Friday, June 19, 2015 - 9:39am | 318In a couple of reports published Thursday, analysts at Brean Capital and Wedbush shared their impressions, highlights and observations from the third day of the 2015 E3 Expo. Both firms look into Electronic Arts Inc. (NASDAQ: EA) and qualify the management’s guidance as conservative,...
-
Does Yelp Need Help?
Thursday, April 30, 2015 - 2:04pm | 615Yelp Inc (NYSE: YELP) reported Q1 results Wednesday and disappointed investors with weak sales. The stock plummeted following the news and recently traded at $39.45, down 23 percent. Analysts gave their take on the results and many remained bullish on the stock. Below are highlights along...
-
What's The Street Think Of Stratasys Now?
Wednesday, April 29, 2015 - 11:43am | 589Stratasys, Ltd. (NASDAQ: SSYS) disappointed investors Tuesday following the release of weak Q1 preliminary results. The stock tumbled amid the news and traded at $41.43, down 19.2 percent. Analysts were quick to weigh in on the announcement. Below are highlights along with current ratings and...
-
Twitter Shares Crumble; Wall Street Reacts
Wednesday, April 29, 2015 - 11:09am | 825Twitter Inc (NYSE: TWTR) reported Q1 earnings Tuesday and disappointed investors with weak results. The stock fell following the news and recently traded at $40.07, down 5.2 percent. Wall Street analysts gave their take on the results. Below are highlights along with current ratings and price...
-
Analyst: Chimerix Govt. Smallpox Pact Worth Up To $435 Million
Thursday, April 16, 2015 - 7:39am | 199Chimerix Inc (NASDAQ: CMRX)'s proposed government contract to produce up to 1.7 million doses of a treatment for smallpox could be worth up to $435 million, an analyst said Wednesday. The company was awarded the sole-source, five-year contract Monday, although it would formally receive it until...
-
Axoim Sees More Upside For LinkedIn
Friday, March 20, 2015 - 10:10am | 335Axiom initiated coverage on LinkedIn Corp (NYSE: LNKD) Friday with a Buy rating and $300 price target. Analyst Victor Anthony felt that Sales Navigator had a "long runway" with less than 2 percent penetration and noted that it could generate $230 million in revenue for 2015....
-
Activision Blizzard Q4 Earnings Preview
Thursday, February 5, 2015 - 5:00pm | 151Activision Blizzard, Inc. (NASDAQ: ATVI) reports Q4 earnings Thursday. The Street expects revenue of $2.24 billion and EPS of $0.88. Wedbush expected revenue of $2.275 million and EPS of $0.91 with flat Q4 sales and FY 2015 guidance to come in above expectations. The firm maintained an...
-
Brean Predicts 'A Skid And A Crash' For Rockwell Medical's Triferic Drug
Monday, January 26, 2015 - 5:25pm | 222Brean Capital reiterated its Sell rating on Rockwell Medical Inc (NASDAQ: RMTI) on Monday following the FDA approval of its Triferic iron replacement product. The firm maintained a $4 price target. Analysts Jonathan Aschoff and Yi Cheng expected “dismal commercial uptake” for the...
-
Broadcom Analyst Roundup
Wednesday, December 10, 2014 - 11:19am | 608Broadcom Corporation (NASDAQ: BRCM) announced a range of shareholder-focused initiatives at its annual Analyst Day on Tuesday. The stock responded by trading higher Wednesday morning with shares surging over 2 percent to $43.64. Below are highlights from analyst comments following the meeting...
-
Analyst Roundup After 3D Systems Q3 Results
Tuesday, November 11, 2014 - 2:39pm | 570Analysts commented on 3D Systems Corporation (NYSE: DDD) after it posted mixed Q3 results Monday. Shares fell Tuesday afternoon to $34.62, down 4.4 percent. Below are analyst comments along with current ratings and price targets. Citi - Neutral, $40 price target “3D Systems...
-
Activision Blizzard Analyst Roundup
Wednesday, November 5, 2014 - 3:49pm | 250Activision Blizzard, Inc. (NASDAQ: ATVI) will face difficult revenue comparisons next year because of the currently strong performance of its "Destiny" video game product, an analyst said Wednesday. Activision beat third-quarter expectations Tuesday, citing its newly launched "...
-
3D Systems Prints Disappointing Results
Friday, August 1, 2014 - 9:09am | 2033D Systems (NYSE: DDD) reported earnings after Thursday's close. Second quarter Q2 EPS and revenues both came in below consensus estimates. Revenue for the quarter was $151.5 million versus a consensus of $162.2 million; organic growth for the quarter was only 10 percent. Non-GAAP EPS...